Correlation Between Gracell Biotechnologies and Lantern Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gracell Biotechnologies and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gracell Biotechnologies and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gracell Biotechnologies and Lantern Pharma, you can compare the effects of market volatilities on Gracell Biotechnologies and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gracell Biotechnologies with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gracell Biotechnologies and Lantern Pharma.

Diversification Opportunities for Gracell Biotechnologies and Lantern Pharma

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Gracell and Lantern is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Gracell Biotechnologies and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and Gracell Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gracell Biotechnologies are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of Gracell Biotechnologies i.e., Gracell Biotechnologies and Lantern Pharma go up and down completely randomly.

Pair Corralation between Gracell Biotechnologies and Lantern Pharma

If you would invest  402.00  in Gracell Biotechnologies on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Gracell Biotechnologies or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy4.55%
ValuesDaily Returns

Gracell Biotechnologies  vs.  Lantern Pharma

 Performance 
       Timeline  
Gracell Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gracell Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Gracell Biotechnologies is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Lantern Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lantern Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Gracell Biotechnologies and Lantern Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gracell Biotechnologies and Lantern Pharma

The main advantage of trading using opposite Gracell Biotechnologies and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gracell Biotechnologies position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.
The idea behind Gracell Biotechnologies and Lantern Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments